Shari A Price-Schiavi

Title: Shari A Price-Schiavi: Innovator in Cancer Detection Technologies

Introduction

Shari A Price-Schiavi is a prominent inventor based in Westminster, MD (US). She has made significant contributions to the field of cancer detection through her innovative research and development of soluble TCR molecules. With a total of 2 patents, her work has the potential to revolutionize how cancer cells are detected and diagnosed.

Latest Patents

Shari's latest patents focus on soluble TCR molecules and methods of use. These patents disclose compositions and methods for detecting cells or tissue that comprise a peptide antigen presented in the context of an MHC or HLA complex. The invention has a wide range of applications, including providing a highly sensitive method for detecting cancer cells. This advancement is crucial for early diagnosis and treatment of cancer, which can significantly improve patient outcomes.

Career Highlights

Throughout her career, Shari has been associated with Altor Bioscience Corporation, where she has played a vital role in advancing cancer detection technologies. Her expertise and innovative approach have positioned her as a key figure in her field.

Collaborations

Shari has collaborated with notable coworkers, including Heather J Belmont and Kimberlyn F Card. These collaborations have further enhanced her research and contributed to the development of groundbreaking technologies in cancer detection.

Conclusion

Shari A Price-Schiavi's contributions to the field of cancer detection through her innovative patents and collaborations highlight her importance as an inventor. Her work continues to pave the way for advancements in medical technology, ultimately benefiting patients and healthcare providers alike.